A. Frequency of post-COVID symptoms lasting ≥ 4 weeks after initial diagnosis as reported by participants 12-months after hospitalization for COVID-19 (N = 242). B. Percent of patients who received, and responded to a given therapy for PASC symptoms within 12-months after hospitalization for COVID-19 (N = 242).</p
Introduction COVID-19 may lead to persistent and potentially incapacitating clinical manifestations ...
International audienceThe risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well...
After mild COVID-19, some outpatients experience persistent symptoms. However, data are scarce and p...
Importance: Short-term and long-term persistent postacute sequelae of COVID-19 (PASC) have not been...
Distribution of symptoms at 3 months among study participants with post COVID-19 condition (n = 1,51...
Post-acute sequelae of COVID-19 (PASC, or ‘Long COVID’) has caused concern but the burden and risk f...
Methods Medline, EMBASE and the Cochrane Library were searched and supplemented with conference and ...
Background: With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are com...
Acute COVID-19 includes symptoms present up to 4 weeks. Live virus is typically present in the res...
Demographics, comorbidities, symptom clusters and 12-month outcome metrics among Therapy Groups (N =...
Background Post-acute COVID-19 Syndrome is now recognized as a complex systemic disease that is ass...
Post-acute sequelae of SARS-CoV-2 (PASC) is defined as persistent symptoms after apparent recovery f...
To assess the prevalence of and factors associated with post-coronavirus disease 2019 (COVID-19) syn...
International audienceObjectives - Persistent post-acute coronavirus disease 2019 (COVID-19) symptom...
International audienceAbout 10% of people infected by severe acute respiratory syndrome coronavirus ...
Introduction COVID-19 may lead to persistent and potentially incapacitating clinical manifestations ...
International audienceThe risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well...
After mild COVID-19, some outpatients experience persistent symptoms. However, data are scarce and p...
Importance: Short-term and long-term persistent postacute sequelae of COVID-19 (PASC) have not been...
Distribution of symptoms at 3 months among study participants with post COVID-19 condition (n = 1,51...
Post-acute sequelae of COVID-19 (PASC, or ‘Long COVID’) has caused concern but the burden and risk f...
Methods Medline, EMBASE and the Cochrane Library were searched and supplemented with conference and ...
Background: With millions of SARS-CoV-2 infections worldwide, increasing numbers of patients are com...
Acute COVID-19 includes symptoms present up to 4 weeks. Live virus is typically present in the res...
Demographics, comorbidities, symptom clusters and 12-month outcome metrics among Therapy Groups (N =...
Background Post-acute COVID-19 Syndrome is now recognized as a complex systemic disease that is ass...
Post-acute sequelae of SARS-CoV-2 (PASC) is defined as persistent symptoms after apparent recovery f...
To assess the prevalence of and factors associated with post-coronavirus disease 2019 (COVID-19) syn...
International audienceObjectives - Persistent post-acute coronavirus disease 2019 (COVID-19) symptom...
International audienceAbout 10% of people infected by severe acute respiratory syndrome coronavirus ...
Introduction COVID-19 may lead to persistent and potentially incapacitating clinical manifestations ...
International audienceThe risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well...
After mild COVID-19, some outpatients experience persistent symptoms. However, data are scarce and p...